These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12397469)

  • 1. Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer.
    Kato T; Tsukamoto E; Kuge Y; Takei T; Shiga T; Shinohara N; Katoh C; Nakada K; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1492-5. PubMed ID: 12397469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.
    Sutinen E; Nurmi M; Roivainen A; Varpula M; Tolvanen T; Lehikoinen P; Minn H
    Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):317-24. PubMed ID: 14628097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11C-acetate PET imaging of prostate cancer.
    Oyama N; Akino H; Kanamaru H; Suzuki Y; Muramoto S; Yonekura Y; Sadato N; Yamamoto K; Okada K
    J Nucl Med; 2002 Feb; 43(2):181-6. PubMed ID: 11850482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.
    Oyama N; Kim J; Jones LA; Mercer NM; Engelbach JA; Sharp TL; Welch MJ
    Nucl Med Biol; 2002 Nov; 29(8):783-90. PubMed ID: 12453586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-11C-acetate kinetics of prostate cancer.
    Schiepers C; Hoh CK; Nuyts J; Seltzer M; Wu C; Huang SC; Dahlbom M
    J Nucl Med; 2008 Feb; 49(2):206-15. PubMed ID: 18199613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
    Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
    J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.
    Souvatzoglou M; Weirich G; Schwarzenboeck S; Maurer T; Schuster T; Bundschuh RA; Eiber M; Herrmann K; Kuebler H; Wester HJ; Hoefler H; Gschwend J; Schwaiger M; Treiber U; Krause BJ
    Clin Cancer Res; 2011 Jun; 17(11):3751-9. PubMed ID: 21493868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dose estimates in humans for (11)C-acetate whole-body PET.
    Seltzer MA; Jahan SA; Sparks R; Stout DB; Satyamurthy N; Dahlbom M; Phelps ME; Barrio JR
    J Nucl Med; 2004 Jul; 45(7):1233-6. PubMed ID: 15235071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.
    Tsuchida T; Takeuchi H; Okazawa H; Tsujikawa T; Fujibayashi Y
    Nucl Med Biol; 2008 Feb; 35(2):171-6. PubMed ID: 18312826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of physiological accumulation of [11C]acetate in normal prostate using positron emission tomography].
    Kato T
    Hokkaido Igaku Zasshi; 2002 Jul; 77(4):359-65. PubMed ID: 12187832
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose.
    Effert PJ; Bares R; Handt S; Wolff JM; Büll U; Jakse G
    J Urol; 1996 Mar; 155(3):994-8. PubMed ID: 8583625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer.
    Oyama N; Akino H; Suzuki Y; Kanamaru H; Sadato N; Yonekura Y; Okada K
    Jpn J Clin Oncol; 1999 Dec; 29(12):623-9. PubMed ID: 10721945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Prostate Cancer with 11C-Acetate PET/CT.
    Spick C; Herrmann K; Czernin J
    J Nucl Med; 2016 Oct; 57(Suppl 3):30S-37S. PubMed ID: 27694168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of prostate cancer with 11C-acetate.
    Dimitrakopoulou-Strauss A; Strauss LG
    J Nucl Med; 2003 Apr; 44(4):556-8. PubMed ID: 12679399
    [No Abstract]   [Full Text] [Related]  

  • 15. 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
    Mena E; Turkbey B; Mani H; Adler S; Valera VA; Bernardo M; Shah V; Pohida T; McKinney Y; Kwarteng G; Daar D; Lindenberg ML; Eclarinal P; Wade R; Linehan WM; Merino MJ; Pinto PA; Choyke PL; Kurdziel KA
    J Nucl Med; 2012 Apr; 53(4):538-45. PubMed ID: 22343504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative measurements of prostatic blood flow and blood volume by positron emission tomography.
    Inaba T
    J Urol; 1992 Nov; 148(5):1457-60. PubMed ID: 1279212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PET/MRI study towards finding the optimal [
    Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Tessem MB; Moestue SA; Bertilsson H; Bathen TF
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):695-703. PubMed ID: 27817158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer.
    Vāvere AL; Kridel SJ; Wheeler FB; Lewis JS
    J Nucl Med; 2008 Feb; 49(2):327-34. PubMed ID: 18199615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging prostate cancer with 11C-choline PET/CT.
    Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
    J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
    Hautzel H; Müller-Mattheis V; Herzog H; Roden W; Coenen HH; Ackermann R; Müller-Gärtner HW; Krause BJ
    Urologe A; 2002 Nov; 41(6):569-76. PubMed ID: 12524944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.